International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 3759-3761
Case Series
Symptomatic and Biochemical Improvement in Hypothyroidism Through Ayurvedic Management: A Case Series
 ,
 ,
 ,
Received
May 17, 2026
Accepted
June 8, 2026
Published
June 20, 2026
Abstract

Hypothyroidism is a prevalent endocrine disorder characterized by inadequate production of thyroid hormones, leading to a generalized slowing of metabolic processes. While levothyroxine remains the standard modern treatment, lifelong dependency and residual symptoms drive patients toward complementary therapies. In Ayurveda, hypothyroidism can be correlated with the functional impairment of Agnimandya and Vata-Kapha dosha imbalance, localized in the Griva (neck) region, manifesting similarly to Galaganda. This case series presents three female patients diagnosed with primary hypothyroidism who were managed exclusively with Ayurvedic formulations, including Kanchanar Guggulu, Ashwagandha Churna, and Varunadi Kashaya. Over a period of 12 weeks, the patients were monitored for symptomatic relief and biochemical improvements (Thyroid Stimulating Hormone, Free T3, and Free T4). Significant clinical improvement was observed in weight management, fatigue, cold intolerance, and constipation. Biochemically, elevated TSH levels were reduced to normal ranges, and T3/T4 levels improved. The findings suggest that Ayurvedic management offers a promising, holistic, and safe approach to restoring thyroid function and alleviating symptoms of hypothyroidism. Further randomized controlled trials are warranted to establish standard protocols.

Keywords
INTRODUCTION

Hypothyroidism is one of the most common endocrine disorders worldwide, primarily affecting women. The condition manifests due to the thyroid gland's inability to produce sufficient thyroid hormones, leading to systemic metabolic deceleration (Chaker et al., 2017). Symptoms include excessive weight gain, lethargy, cold intolerance, menstrual irregularities, and cognitive dullness. The conventional treatment relies on synthetic thyroid hormone replacement (Levothyroxine). However, despite achieving biochemical euthyroidism, many patients continue to experience persistent symptoms and seek alternative therapies, indicating a lacuna in purely synthetic hormone replacement therapy (Panicker, 2011).

 

In Ayurveda, the thyroid gland's functions are primarily governed by Agni (metabolic fire). Hypothyroidism is often conceptualized as a state of Dhatvagni Mandya (cellular metabolic dysfunction) coupled with Kapha and Vata dosha vitiation (Sharma & Dash, 2018). The pathogenesis parallels diseases like Galaganda (goiter) and Apachi. Ayurvedic management focuses on clearing Srotorodha (channel obstruction), stimulating Agni, and balancing the vitiated doshas using specific herbo-mineral preparations. This case series evaluates the efficacy of a customized Ayurvedic treatment protocol in improving both symptomatic profiles and biochemical markers in three hypothyroid patients.

 

 

METHODOLOGY

This study presents a case series of three female patients diagnosed with primary hypothyroidism, managed at an Ayurvedic outpatient department. The research methodology involved a pre- and post-intervention assessment over 12 weeks. Diagnoses were confirmed through biochemical evaluation of Thyroid Stimulating Hormone (TSH), Free T3 (fT3), and Free T4 (fT4). Written informed consent was obtained from all patients.

 

Case 1

A 35-year-old female presented with generalized weakness, unexplained weight gain of 6 kg over six months, hair fall, and constipation. Her baseline thyroid profile revealed a notably elevated TSH of 14.5 mIU/L. She had not initiated conventional hormone replacement.

 

Intervention: The patient was prescribed Kanchanar Guggulu (2 tablets of 500 mg, twice daily), Ashwagandha Churna (3 grams, twice daily with warm water), and Triphala Churna (3 grams at bedtime). The duration of treatment was 12 weeks.

 

Case 2

A 42-year-old female reported severe cold intolerance, joint pain, lethargy, and dry skin. Her initial TSH level was 9.8 mIU/L, with a borderline low fT4.

 

Intervention: She was treated with Varunadi Kashaya (15 ml with equal parts water, twice daily before meals) and Kanchanar Guggulu (2 tablets of 500 mg, twice daily). Dietary modifications (avoiding heavy, oily, and processed foods) were also advised. Treatment continued for 12 weeks.

 

Case 3

A 28-year-old postpartum female complained of persistent fatigue, mood swings, and puffiness of the face. Her baseline TSH was 11.2 mIU/L.

 

Intervention: The prescribed regimen included Kanchanar Guggulu (2 tablets, twice daily) and a combination of Ashwagandha and Shatavari powders (3 grams each, twice daily with milk). The regimen was administered for 12 weeks.

 

RESULT

The results are presented based on the pre- and post-treatment biochemical analysis and subjective symptom tracking. All three patients showed significant improvement in their thyroid profiles (Table 1). Elevated TSH levels were successfully reduced, and T3/T4 levels normalized, indicating restored thyroid gland function without the use of exogenous thyroxine. Clinical symptoms were graded on a subjective scale. All patients reported marked reductions in fatigue, weight stabilization, improved bowel movements, and better thermal regulation (Table 2).

 

Table 1: Biochemical markers before and after 12 weeks of Ayurvedic management.

Patient

TSH Before
(mIU/L)

TSH After
(mIU/L)

fT3 Before
(pg/mL)

fT3 After
(pg/mL)

fT4 Before
(ng/dL)

fT4 After
(ng/dL)

Case 1

14.5

4.2

2.1

3.0

0.7

1.1

Case 2

9.8

3.5

2.4

3.2

0.8

1.2

Case 3

11.2

4.0

2.2

3.1

0.9

1.3


Table 2: Key clinical symptoms improvement.

Patient

Primary Symptoms Before

Status After 12 Weeks

Case 1

Severe fatigue, Constipation, Weight gain

Fatigue reduced, Bowel normal, Weight stable

Case 2

Cold intolerance, Lethargy, Dry skin

Mild cold intolerance, Energy improved

Case 3

Postpartum fatigue, Mood swings, Puffiness

Puffiness resolved, Mood stable, Active

 

DISCUSSION

The observed biochemical and clinical improvements highlight the therapeutic potential of new and important aspects of Ayurvedic interventions in managing hypothyroidism. According to Ayurvedic pharmacology, Kanchanar Guggulu possesses Lekhana (scraping/fat-reducing) and Granti-hara properties, which are highly effective in treating glandular dysfunctions and clearing Srotorodha (channel blockages) in the lymphatic and endocrine systems (Puri et al., 2019). It reduces Kapha dosha and improves tissue-level metabolism (Dhatvagni).

 

Ashwagandha (Withania somnifera) is a renowned adaptogen. Modern studies suggest it has a direct stimulating effect on the thyroid gland, increasing the secretion of T3 and T4 hormones while lowering TSH levels and reducing oxidative stress (Sharma et al., 2018). The inclusion of Varunadi Kashaya and Triphala targeted digestive fire (Jatharagni) correction and relieved accompanying symptoms like constipation and lethargy. The holistic approach not only addressed the biochemical deficiencies but also provided comprehensive relief from the multi-systemic symptoms of the disease, addressing a major lacuna in purely synthetic therapies. The primary limitation of this study is its small sample size and lack of a control group.

 

CONCLUSION

In summary, this case series demonstrates that Ayurvedic management, focusing on Agni correction and dosha pacification through formulations like Kanchanar Guggulu and Ashwagandha, can lead to significant symptomatic and biochemical improvements in patients with primary hypothyroidism. The treatment was well-tolerated with no adverse effects. The novelty of this approach lies in treating the root metabolic cause rather than merely replacing hormones. These findings provide a compelling rationale for larger trials and contribute to the upliftment of the present scientific knowledge in holistic endocrine management.

 

REFERENCES

  1. Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017). Hypothyroidism. The Lancet, 390(10101), 1550–1562. https://doi.org/10.1016/S0140-6736(17)30703-1
  2. Panicker, V. (2011). Genetics of thyroid function and disease. The Clinical Biochemist Reviews, 32(4), 165–175.
  3. Puri, A., Sharma, R., & Gupta, P. (2019). Clinical evaluation of Kanchanar Guggulu in the management of subclinical hypothyroidism: A pilot study. Journal of Ayurveda and Integrative Medicine, 10(2), 120-125.
  4. Sharma, A. K., Basu, I., & Singh, S. (2018). Efficacy and safety of Ashwagandha root extract in subclinical hypothyroid patients: A double-blind, randomized placebo-controlled trial. The Journal of Alternative and Complementary Medicine, 24(3), 243-248. https://doi.org/10.1089/acm.2017.0183
  5. Sharma, P. V., & Dash, V. B. (2018). Charaka Samhita (Vol. 2). Chowkhamba Sanskrit Series Office.
Recommended Articles
Research Article Open Access
Magnetic Resonance Imaging Evaluation of Avascular Necrosis of the Hip in Post-COVID-19 Patients: A Prospective Observational Study
2026, Volume-7, Issue 3 : 3750-3753
Research Article Open Access
Pre- and Post-Donation Changes in Haematological and Biochemical Parameters in Plateletpheresis Donors: A Prospective Study
2026, Volume-7, Issue 3 : 3746-3749
Research Article Open Access
Presenting patterns and management of aggressive angiomyxoma and cellular angiofibroma in the perineum and pelvic spaces
2026, Volume-7, Issue 3 : 3598-3602
Research Article Open Access
Postoperative Morbidity and Recurrence After Salvage Radical Neck Dissection Versus Upfront Neck Dissection for Advanced Cervical Nodal Disease: A Single-Centre Comparative Study
2026, Volume-7, Issue 3 : 3725-3731
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
4 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved